PositoAI
a positivity index
Home Categories Fund houses World
Funds › India › Equity › Sectoral / Thematic › Mirae Asset Healthcare Fund

Mirae Asset Healthcare Fund

Mirae Asset Mutual Fund · Equity · Sectoral / Thematic · Open ended · History since Jul 2018
₹48.29 -1.1% · NAV on 23 Oct 2026 · Direct Growth

← Fund Positivity Score and ranks

Direct · GrowthDirect · IDCWRegular · GrowthRegular · IDCW

Returns Direct Growth · up to 1 year simple %, longer periods yearly average

1 month-9.1%
3 months-3.3%
6 months+8.6%
1 year+10.0%
3 years+21.1%
5 years+15.0%
10 years—
Since start+20.8%

NAV history

Ups and downs

Worst fall from a peak (last 5 years)-18.5%
Peak → lowJan 2022 → Jun 2022
Volatility (last year)13.3%

Volatility shows how much the NAV usually swings in a year; higher means bigger ups and downs.

About this fund

Fund houseMirae Asset Mutual Fund
CategoryEquity · Sectoral / Thematic
TypeOpen ended
Scheme code · ISIN143783 · INF769K01ED6

Same category Sectoral / Thematic · current funds · by 3-year return

Fund1 year3 years5 years
Nippon India Taiwan Equity FundNippon India Mutual Fund +93.6% +57.0% —
HDFC Defence FundHDFC Mutual Fund +11.4% +34.0% —
HDFC Pharma and Healthcare FundHDFC Mutual Fund +15.9% +28.0% —
Nippon India Japan Equity FundNippon India Mutual Fund +25.3% +23.7% +10.8%
Aditya Birla Sun Life International Equity FundAditya Birla Sun Life Mutual Fund +16.0% +22.9% +11.5%
Mirae Asset Healthcare FundMirae Asset Mutual Fund · this fund +10.0% +21.1% +15.0%

255 current funds in Sectoral / Thematic · see all →. Funds are compared only within the same SEBI category.

All versions of this fund

PlanOptionNAV (₹)NAV dateScheme code
DirectGrowth 48.29 23 Oct 2026 143783
DirectIDCW 29.08 23 Oct 2026 143784
RegularGrowth 42.53 23 Oct 2026 143785
RegularIDCW 25.04 23 Oct 2026 143786

Direct plans are bought straight from the fund house and cost less; Regular plans include a distributor's commission. Growth keeps profits invested; IDCW pays them out from time to time.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.